a pioneer in unlocking the patient experience in oncology
Carevive Systems, founded in 2013, is an oncology-focused health technology company dedicated to understanding and improving the cancer patient experience. Their platform enables providers to deliver better quality cancer care, and patients to be more engaged in their treatment, which will improve survival outcomes. Use of Carevive in the clinic unlocks critical data on the real-world cancer patient experience to continuously improve patient care today and provide better access to novel therapies in the future. Carevive is headquartered in North Miami, FloridaView website
Why we invested in Carevive
We believe that bringing the patient experience into the clinical pathway is critical for patient-centric medicine. At the same time, the data collected forms registries of real world evidence, that could be used as virtual control arms for drug development. Debiopharm wants to be in the forefront of this development, because we believe every patient life matters – if the study drug is more efficient than standard of care, we want every patient on the trial to benefit from it.
Discover how we can help you bring your ambition to life
Meet Madelyn Herzfeld
Co-founder of Carevīve
With a background in nursing and public policy, Madelyn Herzfeld was teaching nurses how to optimise patient symptom management when she realised that cancer clinics needed more than education but digital tools to help patients. That’s what sparked her to launch Carevive, a provider of digital tools to improve patient experience by remotely managing treatment planning, monitoring and post treatment care. Learn more about “Maddie” and the events leading up to Debiopharm’s 2020 investment in her healthtech start-up.
March 31, 2022
Carevive Partners with Datavant to Connect Carevive SMART Data™ and Advance Life Science Research
November 11, 2021
Carevive Launches Clinical Oncology Program in Collaboration with NorthShore University HealthSystem
September 24, 2021
Carevive introduces SMART Data™